Medical Training AIPrecision Medicine and Pharmacogenomics
Build the skills to read a pharmacogenomic test result, weigh it against drug labeling and guideline recommendations, and factor it into a medication decision.
What this track covers
This track covers how genetic and biomarker information is used to individualize drug selection and dosing strategy. It focuses on interpreting common pharmacogenomic test panels, recognizing drug-gene pairs with established clinical guidance, and understanding when genetic testing is indicated versus when it adds little to a treatment decision.
What you will practice
- Interpreting a pharmacogenomic test report and identifying actionable drug-gene pairs
- Deciding when genetic testing is indicated before starting or adjusting a medication
- Cross-checking a genetic result against FDA labeling and guideline-based recommendations
- Recognizing phenotype categories (e.g., poor, intermediate, normal, rapid metabolizer) and their clinical relevance
- Communicating genetic test findings and their implications to a patient
Simulator scenario
A patient presents with a new prescription and an available pharmacogenomic test result, and the clinician must decide whether the result changes the drug choice or dose.
Board question topics
- Common drug-gene interactions with guideline-based dosing implications
- Indications for ordering pharmacogenomic testing
- Interpreting metabolizer phenotype categories
- Applying genetic test results to medication selection
Ask the tutor
The tutor only answers from licensed sources (FDA prescribing information, public guidelines and our own material) and says when it has none. Educational use only, never patient-specific advice.
Free during the beta. Sign in with your email, no password.
Start free